Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...

Collection of Efficacy and Safety Data of Chinese Patients Who Have Received Faslodex 250mg Treatment

This study has been terminated.
(The study has been decided to be early terminated for the FAS 500 mg has launched in 2015. The use mothod of 250mg per month in clinical practice is off-label.)
Information provided by (Responsible Party):
AstraZeneca Identifier:
First received: August 19, 2011
Last updated: February 17, 2017
Last verified: February 2017
No Study Results Posted on for this Study
  Study Status: This study has been terminated.
  Study Completion Date: January 2016
  Primary Completion Date: January 2016 (Final data collection date for primary outcome measure)